GO:0140283 HUSH complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140283 (HUSH complex) is a cellular_component term describing a protein complex that mediates transcriptional silencing of mobile genetic elements such as retroviruses and transposable elements.
• In human cells, the HUSH complex is composed of three core subunits: TASOR, PPHLN1 and MPHOSPH8.
• The HUSH complex was discovered through a forward genetic screen for position-effect variegation in human cells, establishing it as a key epigenetic silencing factor.
• HUSH silences integrated retroviruses, transposable elements and quiescent viral genomes, including HSV-1 genomes associated with PML nuclear bodies.
• HUSH function is linked to pluripotency exit, and its disruption alters developmental gene expression programs.
• The complex interacts with accessory factors such as PRC1.6 and is modulated by microproteins, expanding its regulatory repertoire.
Description
The HUSH complex (Human Silencing Hub) is a multi-subunit protein complex that enforces transcriptional silencing of mobile genetic elements, including retroviruses and transposable elements. It is annotated in the Gene Ontology as GO:0140283, a cellular_component term, and in human cells it is composed of TASOR, PPHLN1 and MPHOSPH8. The complex was identified through a genome-wide screen for factors that suppress position-effect variegation, revealing a dedicated epigenetic repressor pathway that protects genome integrity. Because transposable elements and integrated viruses can drive mutagenesis, inflammation and oncogenesis, understanding HUSH complex biology is central to epigenetics, virology and genome stability research. HUSH also contributes to developmental transitions such as pluripotency exit, and its dysfunction has been implicated in disease contexts ranging from viral latency to cancer. This article summarizes the authoritative GO definition, the structural and mechanistic features of the HUSH complex, the genes involved, and the experimental approaches used to study it.
HUSH complex At A Glance
| GO ID | GO:0140283 |
|---|---|
| GO term | HUSH complex |
| Ontology | cellular_component |
| Synonym | None listed in QuickGO |
| Major function | Transcriptional silencing of mobile genetic elements, including retroviruses and transposable elements |
| Core subunits (human) | TASOR, PPHLN1, MPHOSPH8 |
| Discovery context | Identified via a screen for position-effect variegation in human cells |
| Associated factors | PRC1.6 and ERVK3-1 microprotein |
| Disease relevance | Viral latency, cancer, developmental disorders |
What Is GO:0140283?
GO:0140283 (HUSH complex) is defined as a protein complex that mediates transcriptional silencing of mobile genetic elements, such as retroviruses and transposable elements. In human, it is composed of TASOR, PPHLN1 and MPHOSPH8. The term belongs to the cellular_component ontology aspect and has no listed synonyms in QuickGO. Functionally, the complex establishes a repressive chromatin environment at target loci, thereby preventing aberrant expression of integrated foreign sequences and contributing to genome defense.
Why Is HUSH complex Important in Cell Biology?
The HUSH complex is a central node of epigenetic genome defense, silencing retroviruses and transposable elements that would otherwise threaten genome stability. Its discovery revealed a dedicated human silencing pathway distinct from known repressive complexes, and its dysfunction has been linked to viral reactivation, cancer and developmental abnormalities. Because HUSH targets integrated viral genomes, it is also a key determinant of latent reservoir persistence, making it a high-value target for antiviral and gene-editing strategies.
• Silences integrated retroviruses and transposable elements, protecting genome integrity.
• Mediates position-effect variegation in human cells, a classic epigenetic phenomenon.
• Maintains quiescence of HSV-1 genomes associated with PML nuclear bodies.
• Facilitates exit from pluripotency during development.
• Interacts with PRC1.6 for promoter-specific silencing.
• Is modulated by the ERVK3-1 microprotein, linking endogenous retrovirus products to HUSH regulation.
• Represents a potential therapeutic target for reactivating latent viruses.
• Its dysfunction may contribute to cancer and developmental disorders.
Structure and Composition of HUSH complex
Core subunits: TASOR, PPHLN1 and MPHOSPH8
In simple terms: The HUSH complex is built from three main proteins that work together to silence unwanted DNA.
In human cells, the HUSH complex is composed of TASOR, PPHLN1 and MPHOSPH8. These three subunits form the minimal functional unit required for transcriptional silencing of mobile genetic elements. TASOR is thought to act as a scaffold, while MPHOSPH8 and PPHLN1 contribute to chromatin engagement and repression.
Assembly and chromatin recruitment
In simple terms: The complex is recruited to specific regions of the genome to switch genes off.
HUSH assembly is coupled to its recruitment to target loci, where it establishes a repressive chromatin state. The complex is enriched at integrated retroviral sequences and transposable elements, and its binding correlates with transcriptional silencing. Recruitment mechanisms involve recognition of specific chromatin marks and interaction with accessory factors.
Accessory factors: PRC1.6 and microproteins
In simple terms: Other proteins can join the HUSH complex to fine-tune its silencing activity.
PRC1.6 localizes on chromatin with the HUSH complex to mediate promoter-specific silencing. Additionally, the ERVK3-1 microprotein interacts with the HUSH complex, suggesting that endogenous retrovirus-derived peptides can modulate its function. These interactions expand the regulatory repertoire of HUSH beyond its core subunits.
Structural organization and functional domains
In simple terms: Each subunit has specific parts that allow the complex to bind DNA and repress transcription.
The HUSH complex subunits contain domains that mediate protein-protein interactions and chromatin binding. TASOR and MPHOSPH8 are large proteins with multiple predicted domains, while PPHLN1 is smaller and may serve a bridging role. Structural studies are ongoing, but current models suggest a modular architecture that allows flexible target recognition.
Key Genes Involved in GO:0140283 HUSH complex
The following genes encode the core subunits and key accessory factors of the HUSH complex, as well as related silencing machinery.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TASOR | Core subunit of HUSH complex; scaffold for assembly | Knockout abolishes HUSH-mediated silencing |
| PPHLN1 | Core subunit of HUSH complex; required for repression | Essential for position-effect variegation suppression |
| MPHOSPH8 | Core subunit of HUSH complex; chromatin engagement | Target for studying retroviral silencing |
| PRC1.6 | Accessory complex that co-localizes with HUSH | Modulates promoter-specific silencing |
| ERVK3-1 | Endogenous retrovirus encoding a microprotein that interacts with HUSH | Links ERV products to HUSH regulation |
| SETDB1 | Histone methyltransferase often associated with silencing pathways | Potential cooperative factor in HUSH-mediated repression |
| TRIM28 | Scaffold protein in heterochromatin formation | May cooperate with HUSH in silencing |
| HP1 | Heterochromatin protein involved in gene silencing | Downstream effector of repressive chromatin |
| SUV39H1 | Histone methyltransferase for H3K9me3 | Contributes to HUSH-dependent silencing |
| ATF7IP | Partner of SETDB1 in silencing | Potential co-regulator of HUSH targets |
| ZNF638 | Nuclear protein implicated in antiviral silencing | Candidate modulator of HUSH function |
| MORC2 | Chromatin remodeler linked to silencing | Possible interactor in HUSH pathway |
| CHD4 | Nucleosome remodeling subunit of NuRD | May assist HUSH-mediated repression |
| KAP1 | Co-repressor involved in heterochromatin | Functional overlap with HUSH |
| H3K9me3 | Repressive histone mark | Readout of HUSH activity |
| H3K27me3 | Repressive histone mark deposited by PRC complexes | Linked to PRC1.6-HUSH cooperation |
| TASOR2 | Paralog of TASOR with related functions | Potential redundancy in silencing |
| PPHLN1 paralogs | Related proteins with possible roles in silencing | Study of functional diversification |
How Is HUSH complex Regulated?
HUSH complex activity is regulated at multiple levels. Its recruitment to target loci is influenced by chromatin context and accessory factors such as PRC1.6. The ERVK3-1 microprotein can interact with the complex, suggesting that endogenous retrovirus products modulate HUSH function. Additionally, HUSH-mediated silencing is linked to developmental transitions, including pluripotency exit, implying that its activity is developmentally regulated. Post-translational modifications and interaction with other repressive complexes may further fine-tune its activity.
HUSH complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TASOR | Viral latency, cancer | TASOR knockout cells for HSV-1 reactivation |
| MPHOSPH8 | Retroviral silencing, genome stability | MPHOSPH8 knockout for transposon derepression |
| PPHLN1 | Developmental disorders | PPHLN1 knockout in pluripotent stem cells |
| PRC1.6 | Cancer, silencing defects | PRC1.6 perturbation in cancer cell lines |
| ERVK3-1 | Retroviral regulation | Overexpression of ERVK3-1 microprotein |
Viral latency and reactivation
The HUSH complex silences quiescent HSV-1 genomes associated with PML nuclear bodies, contributing to viral latency. Disruption of HUSH can lead to reactivation of latent viruses, making it a target for antiviral strategies aimed at purging latent reservoirs.
Cancer and genome instability
By silencing transposable elements, HUSH protects against insertional mutagenesis and aberrant gene activation that can drive cancer. Loss of HUSH function may lead to derepression of oncogenic elements and genomic instability.
Developmental disorders
HUSH facilitates exit from pluripotency, and its dysfunction may impair developmental transitions. Altered HUSH activity could contribute to developmental abnormalities through misregulation of developmental genes.
From HUSH complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TASOR loss reactivate latent HSV-1? | TASOR knockout in HSV-1 latently infected cells |
| Is MPHOSPH8 required for transposon silencing? | MPHOSPH8 knockout followed by RNA-seq |
| How does PPHLN1 mutation affect pluripotency exit? | PPHLN1 point mutation in stem cells |
| Can tagged HUSH subunits reveal interaction partners? | Knock-in of epitope tags on TASOR |
| Does PRC1.6 cooperate with HUSH at promoters? | PRC1.6 overexpression and ChIP-seq |
| What is the role of ERVK3-1 microprotein? | Overexpression of ERVK3-1 in reporter cells |
How to Study the HUSH complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcript levels of transposons and genes | Assessing derepression after HUSH knockout |
| ChIP-seq | Genome-wide binding of HUSH subunits | Mapping target loci |
| Mass spectrometry | Protein-protein interactions | Identifying accessory factors |
| CRISPR screens | Genes required for silencing | Discovery of HUSH components |
| Reporter assays | Silencing activity at specific loci | Functional validation of HUSH subunits |
| Immunofluorescence | Subcellular localization | Visualizing HUSH at PML bodies |
| ATAC-seq | Chromatin accessibility | Detecting changes upon HUSH loss |
| Ribo-seq | Translation efficiency | Linking silencing to translation |
Transcriptomics and RNA-seq
RNA-seq is used to measure derepression of transposable elements and retroviruses upon HUSH perturbation. Comparative transcriptomics can identify target genes and pathways affected by HUSH loss.
Chromatin immunoprecipitation and sequencing
ChIP-seq for HUSH subunits or repressive histone marks reveals binding sites and chromatin states at target loci. This approach maps HUSH occupancy genome-wide.
Proteomics and interactomics
Affinity purification coupled to mass spectrometry identifies HUSH interaction partners, including PRC1.6 and microproteins. This helps define the composition and regulatory network of the complex.
Imaging and reporter assays
Fluorescence microscopy and reporter systems visualize HUSH-mediated silencing and viral reactivation. Live-cell imaging can track the dynamics of HUSH recruitment.
How CRISPR Can Be Used to Study GO:0140283 HUSH complex
Knockout
CRISPR knockout of TASOR, PPHLN1 or MPHOSPH8 abolishes HUSH-mediated silencing, leading to reactivation of transposable elements and latent viruses. Knockout models are essential for defining the core subunits required for repression.
Point Mutation
Point mutations can dissect domain-specific functions of HUSH subunits, such as chromatin binding or protein interactions. These models help distinguish between structural and catalytic roles.
Knock-in
Knock-in of epitope tags or fluorescent reporters enables visualization and affinity purification of HUSH subunits in native contexts. Tagged knock-in models facilitate interactome and imaging studies.
Overexpression
Overexpression of HUSH subunits or accessory factors such as PRC1.6 can enhance silencing and reveal dose-dependent effects. Overexpression of the ERVK3-1 microprotein modulates HUSH activity.
How EDITGENE Supports HUSH complex Research
Researchers studying HUSH complex-related genes often need to determine whether a candidate gene is causally involved in transcriptional silencing, viral latency or developmental transitions. Rigorous functional studies require precise genetic models that recapitulate loss-of-function, gain-of-function or tagged alleles in relevant cell types. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate HUSH complex research.
Contact EDITGENE today to design your custom CRISPR model for HUSH complex research.
Frequently Asked Questions About HUSH complex
What is the HUSH complex?
The HUSH complex is a protein complex that mediates transcriptional silencing of mobile genetic elements such as retroviruses and transposable elements, composed of TASOR, PPHLN1 and MPHOSPH8 in human cells.
What genes are involved in the HUSH complex?
The core genes are TASOR, PPHLN1 and MPHOSPH8, with accessory factors including PRC1.6 and the ERVK3-1 microprotein.
What is GO:0140283?
GO:0140283 is the Gene Ontology identifier for the HUSH complex, a cellular_component term describing a transcriptional silencing complex.
How does the HUSH complex silence genes?
It is recruited to target loci where it establishes a repressive chromatin environment, preventing transcription of integrated retroviruses and transposable elements.
What diseases are linked to the HUSH complex?
HUSH is linked to viral latency, cancer and developmental disorders through its role in silencing mobile genetic elements.
Can HUSH complex be targeted for antiviral therapy?
Yes, disrupting HUSH can reactivate latent viruses such as HSV-1, suggesting therapeutic potential for latency reversal.
What methods are used to study the HUSH complex?
Common methods include RNA-seq, ChIP-seq, proteomics, CRISPR screens and imaging.
What is the role of TASOR in HUSH?
TASOR is a core subunit that acts as a scaffold for complex assembly and is required for silencing.
How is the HUSH complex regulated?
Its activity is modulated by accessory factors like PRC1.6 and the ERVK3-1 microprotein, and it is developmentally regulated during pluripotency exit.
Where can I get HUSH complex knockout cell lines?
EDITGENE provides custom CRISPR knockout, knock-in and overexpression models for HUSH complex genes.
Conclusion
The HUSH complex (GO:0140283) is a critical epigenetic silencing machine that protects the genome from mobile genetic elements and regulates developmental transitions. Its core subunits TASOR, PPHLN1 and MPHOSPH8, along with accessory factors, form a versatile repressor that is implicated in viral latency, cancer and developmental biology. Continued research using precise CRISPR models will further illuminate its mechanisms and therapeutic potential.
References
- 1. Lehner PJ. 2025. Silencing by the HUSH Epigenetic Transcriptional Repressor Complex.. Annu Rev Biochem 94(1):361-386 PMID: 40540752
- 2. Tchasovnikarova IA et al.. 2015. GENE SILENCING. Epigenetic silencing by the HUSH complex mediates position-effect variegation in human cells.. Science 348(6242):1481-1485 PMID: 26022416
- 3. Müller I et al.. 2024. Keep quiet: the HUSH complex in transcriptional silencing and disease.. Nat Struct Mol Biol 31(1):11-22 PMID: 38216658
- 4. Roubille S et al.. 2024. The HUSH epigenetic repressor complex silences PML nuclear body-associated HSV-1 quiescent genomes.. Proc Natl Acad Sci U S A 121(49):e2412258121 PMID: 39589886
- 5. Wang B et al.. 2025. The HUSH complex facilitates the exit of pluripotency.. Commun Biol 8(1):1679 PMID: 41291012
- 6. Seczynska M et al.. 2023. The sound of silence: mechanisms and implications of HUSH complex function.. Trends Genet 39(4):251-267 PMID: 36754727
- 7. Jayatissa A et al.. 2025. The ERVK3-1 Microprotein Interacts with the HUSH Complex.. Biochemistry 64(15):3372-3381 PMID: 40699144
- 8. Rodríguez TC et al.. 2024. PRC1.6 localizes on chromatin with the human silencing hub (HUSH) complex for promoter-specific silencing.. bioRxiv PMID: 39026796
